Spontaneous epileptiform discharges in a mouse model of Alzheimer's disease are suppressed by antiepileptic drugs that block sodium channels (Q45348858)

From Wikidata

Jump to navigation Jump to search

scientific article published on March 1, 2011

Language	Label	Description	Also known as
English	Spontaneous epileptiform discharges in a mouse model of Alzheimer's disease are suppressed by antiepileptic drugs that block sodium channels	scientific article published on March 1, 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Spontaneous epileptiform discharges in a mouse model of Alzheimer's disease are suppressed by antiepileptic drugs that block sodium channels (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Alzheimer's disease

0 references

7

object named as

Asla Pitkänen

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

author name string

Sofya Ziyatdinova

1

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Kestutis Gurevicius

2

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Nino Kutchiashvili

3

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Tamuna Bolkvadze

4

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Jari Nissinen

5

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Heikki Tanila

6

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21300523

23 November 2024

publication date

1 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

March 2011

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21300523

23 November 2024

full work available at URL

https://api.elsevier.com/content/article/PII:S0920121111000076?httpAccept=text/xml

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

https://api.elsevier.com/content/article/PII:S0920121111000076?httpAccept=text/plain

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Epilepsy Research

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

94

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

75-85

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Incidence and predictors of seizures in patients with Alzheimer's disease

1

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Alzheimer's disease underlies some cases of complex partial status epilepticus

2

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease

3

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Correlation analysis between anticonvulsant ED50 values of antiepileptic drugs in mice and rats and their therapeutic doses and plasma levels

4

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Effects of standard anticonvulsant drugs on different patterns of epileptiform discharges induced by 4-aminopyridine in combined entorhinal cortex-hippocampal slices

5

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

beta-Amyloid increases dendritic Ca2+ influx by inhibiting the A-type K+ current in hippocampal CA1 pyramidal neurons

6

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Valproate decreases EEG synchronization in a use-dependent manner in idiopathic generalized epilepsy

7

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Antiepileptic drugs abolish ictal but not interictal epileptiform discharges in vitro

8

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Influence of levetiracetam on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice

9

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Effects of antiepileptic drugs on 4-aminopyridine-induced epileptiform activity in young and adult rat hippocampus

10

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Activation of K+ channels and suppression of neuronal activity by secreted beta-amyloid-precursor protein.

11

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Effect of lamotrigine treatment on status epilepticus-induced neuronal damage and memory impairment in rat.

12

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Seizures and myoclonus in patients with Alzheimer's disease.

13

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Epilepsy presenting as AD: neuroimaging, electroclinical features, and response to treatment

14

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Intracellular amyloid induces impairments on electrophysiological properties of cultured human neurons

15

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Non-proteolytic effect of beta-site APP-cleaving enzyme 1 (BACE1) on sodium channel function

16

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase

17

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Modulation of 'A'-type K+ current by rodent and human forms of amyloid beta protein

18

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Presenilin/gamma-secretase-mediated cleavage of the voltage-gated sodium channel beta2-subunit regulates cell adhesion and migration

19

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

BACE1 regulates voltage-gated sodium channels and neuronal activity

20

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene

21

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Prevalence and causes of seizures at the time of diagnosis of probable Alzheimer's disease.

22

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Pharmacodynamic and pharmacokinetic characterization of interactions between levetiracetam and numerous antiepileptic drugs in the mouse maximal electroshock seizure model: an isobolographic analysis

23

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Seizures in Alzheimer's disease: clinicopathologic study.

24

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy.

25

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Amyloid beta oligomers (A beta(1-42) globulomer) suppress spontaneous synaptic activity by inhibition of P/Q-type calcium currents.

26

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

A new model of chronic temporal lobe epilepsy induced by electrical stimulation of the amygdala in rat.

27

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Effect of antiepileptic drugs on spontaneous seizures in epileptic rats

28

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease

29

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Epilepsy and cognitive impairments in Alzheimer disease

31

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models

34

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Modification of seizure activity by electrical stimulation. II. Motor seizure

35

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Recurrent seizures in patients with dementia: frequency, seizure types, and treatment outcome

36

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Myoclonus, seizures, and paratonia in Alzheimer disease

37

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Advanced Alzheimer's disease is a risk factor for late-onset seizures

38

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Assessment of CNS effects of antiepileptic drugs by using quantitative EEG measures

39

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Seizures in Alzheimer disease: who, when, and how common?

40

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors.

41

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Lithium, a common drug for bipolar disorder treatment, regulates amyloid-beta precursor protein processing

43

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Seizure susceptibility and mortality in mice that over-express amyloid precursor protein

46

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Axon initial segment dysfunction in epilepsy

47

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Enhancement of outward potassium current may participate in beta-amyloid peptide-induced cortical neuronal death

48

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy

49

1 reference

10.1016/J.EPLEPSYRES.2011.01.003

https://api.crossref.org/works/10.1016/J.EPLEPSYRES.2011.01.003

23 November 2024

Identifiers

10.1016/J.EPLEPSYRES.2011.01.003

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45348858&oldid=2278851033"